
Anup Wadhawan
About Anup Wadhawan
Data last updated:
Anup Wadhawan is a Director at Glaxosmithkline Pharmaceuticals Limited (since 2025), Director at Aequs Limited (since 2025) and Additional Director at Vistaar Financial Services Private Limited (since 2025), and holds 10 more current directorships. The companies operate in Pharma, Consumer Goods and Financial Services. The 10 current companies with reported revenue have a combined latest revenue of ₹8,768 Cr; the largest is Glaxosmithkline Pharmaceuticals Limited at ₹3,895 Cr (FY 2025). Earlier, Anup Wadhawan was a Nominee Director at Hindustan Diamond Company Private Limited (2011–2012) and Director at Sports Goods & Toys Export Promotion Council (2011–2012) and 4 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 26 Mar 2025 | 1924 | ₹3,895 Cr (FY 2025) | Active | |
| Director | 25 Apr 2025 | 2000 | ₹1,296 Cr (FY 2026) | Active | |
| Additional Director | 12 Nov 2025 | 1991 | ₹924 Cr (FY 2025) | Active | |
| Director | 01 Apr 2024 | 2005 | ₹823 Cr (FY 2025) | Active | |
| Director | 18 Feb 2023 | 2020 | ₹713 Cr (FY 2025) | Active | |
| Director | 21 Jul 2025 | 2015 | ₹693 Cr (FY 2025) | Active | |
| Director | 11 Sep 2024 | 1994 | ₹251 Cr (FY 2025) | Active | |
| Director | 27 May 2023 | 2021 | ₹107 Cr (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Nominee Director | 29 Jun 2011 | 1978 | ₹4.47 Cr (FY 2016) | Under Liquidation | |
| Director | 31 Mar 2011 | 1958 | ₹9.30 Cr (FY 2024) | Active | |
| Nominee Director | 14 Aug 2013 | 2002 | Active | ||
| Nominee Director | 27 Nov 2012 | 2012 | ₹6.3 Lakh (FY 2023) | Active | |
| Nominee Director | 06 Apr 2011 | 1966 | ₹409 Cr (FY 2025) | Active | |
| Nominee Director | 01 Aug 2018 | 2017 | ₹700 Cr (FY 2023) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Anup Wadhawan
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Anup Wadhawan
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Anup Wadhawan
Anup Wadhawan currently holds 13 directorships: Glaxosmithkline Pharmaceuticals Limited (Director, since 26 Mar 2025, revenue ₹3,895 Cr (FY 2025)); Aequs Limited (Director, since 25 Apr 2025, revenue ₹1,296 Cr (FY 2026)); Vistaar Financial Services Private Limited (Additional Director, since 12 Nov 2025, revenue ₹924 Cr (FY 2025)); Yatra Online Limited (Director, since 01 Apr 2024, revenue ₹823 Cr (FY 2025)); Credavenue Private Limited (Director, since 18 Feb 2023, revenue ₹713 Cr (FY 2025)); and 8 more.
Anup Wadhawan was first appointed on 31 Mar 2011 as Director at Sports Goods & Toys Export Promotion Council. The most recent appointment on record is 12 Nov 2025 at Vistaar Financial Services Private Limited.
The 10 current companies of Anup Wadhawan that report revenue have a combined latest revenue of ₹8,768 Cr: Glaxosmithkline Pharmaceuticals Limited ₹3,895 Cr (FY 2025); Aequs Limited ₹1,296 Cr (FY 2026); Vistaar Financial Services Private Limited ₹924 Cr (FY 2025); Yatra Online Limited ₹823 Cr (FY 2025); Credavenue Private Limited ₹713 Cr (FY 2025); and 5 more.
Anup Wadhawan held 6 earlier board appointments: Hindustan Diamond Company Private Limited (Nominee Director, 29 Jun 2011 to 26 Sep 2012); Sports Goods & Toys Export Promotion Council (Director, 31 Mar 2011 to 23 Nov 2012); Agriculture Insurance Company Of India Limited (Nominee Director, 14 Aug 2013 to 28 Oct 2015); National Financial Holdings Company Limited (Nominee Director, 27 Nov 2012 to 08 Jan 2014); The Gem And Jewellery Export Promotion Council (Nominee Director, 06 Apr 2011 to 27 Sep 2012); and 1 more.
The current boards of Anup Wadhawan's companies include Ajay Avinash Nadkarni (Glaxosmithkline Pharmaceuticals Limited), Bhushan Arun Akshikar (Glaxosmithkline Pharmaceuticals Limited), Manu Anand (Glaxosmithkline Pharmaceuticals Limited), Renu Sud Karnad (Glaxosmithkline Pharmaceuticals Limited), Ronojit Biswas (Glaxosmithkline Pharmaceuticals Limited), Ronojit Biswas (Glaxosmithkline Pharmaceuticals Limited), among others.